Your 2-Year LOE Window Is a 5-Year Death March: The Real Pharmaceutical Patent Cliff Timeline
Every brand team runs the same model. The compound patent expires on a known date. You build a 24-month revenue […]
Every brand team runs the same model. The compound patent expires on a known date. You build a 24-month revenue […]
The expiration date on a blockbuster drug’s primary patent is almost never the date generic competition arrives. Between that printed
Every few years, a mid-size generic manufacturer files a Paragraph IV certification against a blockbuster drug, gets sued by a
Data Beats Capital: Why the Real Challenger in Pharma IP Is the One Who Knows More Read Post »
Pharmaceutical patent litigation produces more text per dollar at stake than almost any other legal domain. A single Hatch-Waxman case
Sentiment Analysis in Patent Litigation: How to Predict Pharmaceutical Case Outcomes Read Post »
The conventional wisdom in generic pharmaceuticals is seductive in its simplicity: be first, win big. File first, launch first, collect
Every commercial contract negotiation in pharmaceuticals has a clock running in the background. That clock is the patent expiry date,
Patent Expiry Timing: The Payer’s Playbook for Value-Based Contracting Offers Read Post »
The first generic filer gets the headlines. The second entrant often gets the margin. In the United States pharmaceutical market,
The pharmaceutical patent system was designed for a different drug. A small molecule, synthesized in a lab, dosed the same
Drug Patents Are Breaking: How Personalized Medicine Is Exposing the Cracks Read Post »
Quick Summary: Traditional pharmaceutical market research tells you what happened yesterday. A patent analyst suite tells you what will happen
Get fresh news and insights, drug patent expirations & more…